METASTATIC ACRAL MELANOMA
Clinical trials for METASTATIC ACRAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ACRAL MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC ACRAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a morning shot fight cancer better?
Disease control Recruiting nowThis study is testing whether giving two immunotherapy drugs (ipilimumab and nivolumab) at specific times of day improves how well they work for advanced melanoma. Researchers want to see if receiving treatment in the morning, afternoon, or late afternoon leads to better survival…
Matched conditions: METASTATIC ACRAL MELANOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Custom-Made vaccine trial launches for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing the safety of a personalized vaccine designed to train a patient's immune system to attack their specific cancer. It is for adults with advanced breast cancer, melanoma, or non-small cell lung cancer that has continued to grow despite standard tr…
Matched conditions: METASTATIC ACRAL MELANOMA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC